Jim Simons Harvard Bioscience Inc Transaction History
Renaissance Technologies LLC
- $63.6 Billion
- Q1 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Renaissance Technologies LLC holds 702,478 shares of HBIO stock, worth $2.04 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
702,478
Previous 720,378
2.48%
Holding current value
$2.04 Million
Previous $3.85 Million
22.7%
% of portfolio
0.0%
Previous 0.01%
Shares
22 transactions
Others Institutions Holding HBIO
# of Institutions
92Shares Held
32.8MCall Options Held
4KPut Options Held
2.2K-
B. Riley Asset Management, LLC Dallas, TX2.83MShares$8.25 Million5.14% of portfolio
-
Black Rock Inc. New York, NY2.83MShares$8.25 Million0.0% of portfolio
-
Punch & Associates Investment Management, Inc. Edina, MN2.77MShares$8.07 Million0.71% of portfolio
-
Harvey Partners, LLC Tarrytown, NY2.56MShares$7.44 Million1.17% of portfolio
-
Amh Equity LTD2.32MShares$6.76 Million10.16% of portfolio
About HARVARD BIOSCIENCE INC
- Ticker HBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 41,636,500
- Market Cap $121M
- Description
- Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...